Tamsulosin attenuates high glucose- induced injury in glomerular endothelial cells

References

• Typiak M, Piwkowska A. Antiinflammatory actions of klotho: implications for therapy of diabetic nephropathy. Int J Mol Sci. 2021;22(2):956.
   PubMed Web of Science ®Google Scholar
• Ritz E, Rychlík I, Locatelli F, et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34(5):795–808.
   PubMed Web of Science ®Google Scholar
• Yiu WH, Lin M, Tang SC. Toll-like receptor activation: from renal inflammation to fibrosis. Kidney Int Suppl. 2014;4(1):20–25.
   PubMed Web of Science ®Google Scholar
• Petreski T, Piko N, Ekart R, et al. Review on inflammation markers in chronic kidney disease. Biomedicines. 2021;9(2):182.
   PubMed Web of Science ®Google Scholar
• Maezawa Y, Takemoto M, Yokote K. Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes. J Diabetes Investig. 2014;6(1):3–15.
   PubMed Web of Science ®Google Scholar
• Fu J, Wei C, Zhang W, et al. Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice. Kidney Int. 2018;94(2):326–345.
   PubMed Web of Science ®Google Scholar
• Fu J, Lee K, Chuang PY, et al. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Am J Physiol Renal Physiol. 2014;308(4):F287–97.
   PubMed Web of Science ®Google Scholar
• Kanwar YS, Sun L, Xie P. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011;6(1):395–423.
   PubMed Web of Science ®Google Scholar
• Mukohara S, Mifune Y, Inui A, et al. In vitro and in vivo tenocyte-protective effectiveness of dehydroepiandrosterone against high glucose-induced oxidative stress. BMC Musculoskelet Disord. 2021;22(1):519.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang M, Zhou H, et al. Salusin-β mediates high glucose-induced inflammation and apoptosis in retinal capillary endothelial cells via a ROS-dependent pathway in diabetic retinopathy. Diabetes Metab Syndr Obes. 2021;14:2291–2308.
   PubMed Web of Science ®Google Scholar
• Cotecchia S. α (1)-adrenergic receptors: diversity of signaling networks and regulation. J Recep Signal Transd Res. 2010;30(6):410–419.
   PubMed Web of Science ®Google Scholar
• Hu ZW, Shi XY, Lin RZ, Hoffman BB. Contrasting signaling pathways of α1a-and α1b-adrenergic receptor subtype activation of phosphatidylinositol 3-kinase and ras in transfected NIH3T3 cells. Mol Endocrinol. 1999;13(1):3–14.
   PubMedGoogle Scholar
• Parsons JK, Hergan LA, Sakamoto K, et al. Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol. 2007;177(3):983–987.
   PubMed Web of Science ®Google Scholar
• Alqudah A, Eastwood KA, Jerotic D, et al. FKBPL and SIRT-1 are downregulated by diabetes in pregnancy impacting on angiogenesis and endothelial function. Front Endocrinol (Lausanne). 2021;12:650328.
   PubMed Web of Science ®Google Scholar
• Hennenberg M, Acevedo A, Wiemer N, et al. Non-adrenergic, tamsulosin-insensitive smooth muscle contraction is sufficient to replace alpha (1) -adrenergic tension in the human prostate. Prostate. 2017;77(7):697–707.
   PubMed Web of Science ®Google Scholar
• Duan QN, Jia Y, Qin Y, et al. Narciclasine attenuates LPS-induced acute lung injury in neonatal rats through suppressing inflammation and oxidative stress. Bioengineered. 2020;11(1):801–810.
   PubMed Web of Science ®Google Scholar
• Korish AA, Abdel Gader AG, Korashy HM, et al. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis. Chem Biol Interact. 2015;229:100–108.
   PubMed Web of Science ®Google Scholar
• Reidy K, Kang HM, Hostetter T, et al. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014;124(6):2333–2340.
   PubMed Web of Science ®Google Scholar
• Koike N, Takamura T, Kaneko S. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF- stimulation, and effects of aphosphodiesterase inhibitor. Life Sci. 2007;80(18):1721–1728.
   PubMed Web of Science ®Google Scholar
• Raedke HH, Meier B, Topley N, et al. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int. 1990;37(2):767–775.
   PubMed Web of Science ®Google Scholar
• Singh DK, Winocour P, Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol. 2010;7(3):176–184.
   PubMed Web of Science ®Google Scholar
• Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252.
   PubMed Web of Science ®Google Scholar
• Chen M, Chen Z, Huang D, et al. Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway. Pulm Pharmacol Ther. 2020;65:102000.
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang J, Sun Y, et al. Sun J.Long non-coding RNA NKILA weakens TNF-α-induced inflammation of MRC-5 cells by miR-21 up-regulation. Artif Cells Nanomed Biotechnol. 2020;48(1):498–505.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhao S, Yuan H, et al. Knockdown of Ror2 suppresses TNF‑α‑induced inflammation and apoptosis in vascular endothelial cells. Mol Med Rep. 2020;22(4):2981–2989.
   PubMed Web of Science ®Google Scholar
• Li X, Wu TT, Chen J, et al. Elevated expression levels of serum insulin-like growth factor-1, tumor necrosis factor-α and vascular endothelial growth factor 165 might exacerbate type 2 diabetic nephropathy. J Diabetes Investig. 2017;8(1):108–114.
   PubMed Web of Science ®Google Scholar
• Bertani T, Abbate M, Zoja C, et al. Tumor necrosis factor induces glomerular damage in rabbit. Am J Pathol. 1989;134:419–430.
   PubMed Web of Science ®Google Scholar
• King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8s):1527–1534.
   PubMedGoogle Scholar
• Karamian A, Paktinat S, Esfandyari S, et al. Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells. Hum Exp Toxicol. 2020;40(4):649–660.
   PubMed Web of Science ®Google Scholar
• Zeng O, Li F, Li Y, et al. Effect of Novel Gasotransmitter hydrogen sulfide on renal fibrosis and connexins expression in diabetic rats. Bioengineered. 2016;7(5):314–320.
   PubMed Web of Science ®Google Scholar
• Cheng S, Pollock AS, Mahimkar R, et al. Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J. 2006;20(11):1898–1900.
   PubMed Web of Science ®Google Scholar
• Gu YY, Liu XS, Huang XR, et al. Diverse role of TGF-β in kidney disease. Front Cell Dev Biol. 2020;8:123.
   PubMed Web of Science ®Google Scholar
• Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15:144–158.
   PubMed Web of Science ®Google Scholar
• Wang B, Komers R, Carew R, et al. Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol. 2012;23(2):252–265.
   PubMed Web of Science ®Google Scholar
• Chakravarthy A, Khan L, Bensler NP, et al. TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun. 2018;9(1):4692.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhou Y, Zhang Y, et al. Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-β1/p38 MAPK pathway. Biomed Pharmacother. 2019;115:108895.
   PubMed Web of Science ®Google Scholar
• Dou F, Liu Y, Liu L, et al. Aloe-emodin ameliorates renal fibrosis via inhibiting PI3K/Akt/mTOR signaling pathway In Vivo and In Vitro. Rejuvenation Res. 2019;22(3):218–229.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang H, Tu Y, et al. WNT1-inducible signaling protein-1 mediates TGF-β1-induced renal fibrosis in tubular epithelial cells and unilateral ureteral obstruction mouse models via autophagy. J Cell Physiol. 2020;235(3):2009–2022.
   PubMed Web of Science ®Google Scholar
• Lu Q, Wang WW, Zhang MZ, et al. ROS induces epithelial-mesenchymal transition via the TGF-β1/PI3K/Akt/mTOR pathway in diabetic nephropathy. Exp Ther Med. 2019;17:835–846.
   PubMed Web of Science ®Google Scholar
• Wang S, Sun Z, Yang S, et al. CTRP6 inhibits cell proliferation and ECM expression in rat mesangial cells cultured under TGF-β1. Biomed Pharmacother. 2018;97:280–285.
   PubMed Web of Science ®Google Scholar
• Chen J, He Q, Dai M, et al. HSP75 inhibits TGF-β1-induced apoptosis by targeting mitochondria in human renal proximal tubular epithelial cells. Biochem Biophys Res Commun. 2019;515(1):64–71.
   PubMed Web of Science ®Google Scholar
• Navarro-González JF, Mora-Fernández C, De Fuentes MM, et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011;7(6):327–340.
   PubMed Web of Science ®Google Scholar
• Kolati SR, Kasala ER, Bodduluru LN, et al. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway. Environ Toxicol Pharmacol. 2015;39(2):690–699.
   PubMed Web of Science ®Google Scholar